Abstract
In this issue of Blood, Ahn et al report on Pneumocystis jirovecii pneumonia (PCP) complicating ibrutinib monotherapy for progressive chronic lymphocytic leukemia (CLL). These clinically important data evoke important questions about PCP, CLL, and ibrutinib therapy.1
Cite
CITATION STYLE
APA
Zent, C. S. (2016, October 13). CLL: An acquired immunodeficiency disease. Blood. American Society of Hematology. https://doi.org/10.1182/blood-2016-08-734475
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free